Oxford University Press

SHERPA: Yellow

People

  1. De Angelis
    De Angelis
  2. Drilon
    Drilon
  3. Motzer
    Motzer
  4. Mellinghoff
    Mellinghoff
  5. Rosenblum
    Rosenblum
  6. Shuman
    Shuman
  7. Dunkel
    Dunkel
  8. Karajannis
    Karajannis
  9. Saltz
    Saltz
  10. Souweidane
    Souweidane

Groups

  1. Department of Medicine (1985)
  2. Solid Tumor Oncology Division (1617)
  3. GSK Faculty (763)
  4. Survivorship Research (636)
  5. Population Sciences Research Program (613)
  6. Epidemiology and Biostatistics (463)
  7. Department of Pathology and Laboratory Medicine (414)
  8. Gastrointestinal Oncology Service (385)
  9. Genitourinary Oncology Service (364)
  10. Tow Center for Developmental Oncology (TCDO) (352)
Search Within
Formats
  1. Journal Article (2095)
  2. Meeting Abstract (2072)
  3. Book Section (192)
  4. Review (89)
  5. Editorial (80)
  6. Guidelines (36)
  7. Correspondence (24)
  8. Book Whole (18)
  9. Conference Paper (15)
  10. Research Letter (9)
Groups
  1. Department of Medicine (1985)
  2. Solid Tumor Oncology Division (1617)
  3. GSK Faculty (763)
  4. Survivorship Research (636)
  5. Population Sciences Research Program (613)
  6. Epidemiology and Biostatistics (463)

More Groups

People
  1. Lisa De Angelis (119)
  2. Alexander Drilon (108)
  3. Robert Motzer (96)
  4. Ingo Mellinghoff (93)
  5. Marc Rosenblum (87)
  6. Stewart Shuman (87)

More People

Years
  1. 2025 (83)
  2. 2024 (304)
  3. 2023 (320)
  4. 2022 (331)
  5. 2021 (323)
  6. 2020 (325)

More Years

Publications
  1. Annals of Oncology (1668)
  2. Neuro-Oncology (845)
  3. JNCI: Journal of the National Cancer Institute (482)
  4. Nucleic Acids Research (209)
  5. Clinical Infectious Diseases (138)
  6. American Journal of Clinical Pathology (105)

More Publications

Results (4630)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Update on GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma
    Meeting Abstract

    Lassman, A.; Alexander, B.; Berry, D.; Berry, N.; Buxton, M.; Colman, H.; Gan, H.; de Groot, J.; de la Fuente, M.; Drappatz, J.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Phase 1 dose finding study evaluating the safety, tolerability, and efficacy of iopofosine I 131 in children, adolescents, and young adults with inoperable relapsed or refractory high-grade gliomas: A trial-in-progress
    Meeting Abstract

    Sait, S. F.; Morgenstern, D. A.; Pandit-Taskar, N.; Das, A.; Pudel, M.; Fisher, C.; Zanzonico, P.; Haque, S.; Longcor, J.; Shustov, A.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Central nervous system bridging radiotherapy (CNS-BRT) achieves rapid cytoreduction prior to car T-cell therapy for aggressive B-cell lymphomas
    Meeting Abstract

    Cederquist, G.; Schefflein, J.; Devlin, S.; Shah, G.; Shouval, R.; Hubbeling, H.; Tringale, K.; Fregonese, B.; Hajj, C.; Boardman, A.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Patterns of intracranial response and relapse after CNS-directed radiotherapy (CNS-RT) for patients with chemorefractory or progressive secondary CNS lymphoma (SCNSL)
    Meeting Abstract

    Cederquist, G.; Tringale, K.; Hajj, C.; Moore, Z.; Hubbeling, H.; Dreyfuss, A.; Fregonese, B.; Falchi, L.; Scordo, M.; Grommes, C.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • IDH-mutant glioma patients treated with vorasidenib: Ongoing data from the vorasidenib expanded access program
    Meeting Abstract

    Cloughesy, T.; Peters, K.; Colman, H.; Taylor, J.; Mellinghoff, I.; Shih, H.; Chacar, C.; Dewey, J.; Wen, P.
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • A phase 1, randomized, perioperative trial of vorasidenib and ivosidenib in IDH1-mutant diffuse glioma: Updated results
    Meeting Abstract

    Mellinghoff, I.; Wen, P.; Taylor, J.; Taylor, E.; Arrillaga-Romany, I.; Ellingson, B.; Mahboub-Johnson, P.; Baron, E.; Hassan, I.; Steelman, L.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Phase I/II study of stereotactic radiosurgery with concurrent olaparib followed by adjuvant durvalumab and physician's choice systemic therapy in subjects with breast cancer brain metastases (SOLARA)
    Meeting Abstract

    Shen, C.; Abdou, Y.; Chen, L.; Tan, X.; Gupta, G.; Lynce, F.; Lobbous, M.; Stringer-Reasor, E.; Anders, C.
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Prospective germline sequencing of patients with gliomas, glioneuronal or neuronal tumors
    Meeting Abstract

    Lin, A.; Nandakumar, S.; Mehine, M.; Kemel, Y.; Mandelker, D.; Karajannis, M.; Sait, S. F.; Gavrilovic, I.; Pentsova, E.; Schaff, L.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Treatment and outcomes of frail patients with newly diagnosed high-grade gliomas: Should we consider changing our treatment approach?
    Meeting Abstract

    Sielski, N.; Reiner, A.; Schaff, L.; Imber, B.; Pike, L.; Carver, A.; Pentsova, E.
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Integration of functional magnetic resonance imaging into stereotactic radiosurgery planning to reduce symptomatic radiation necrosis
    Meeting Abstract

    Gui, C.; Jenabi, M.; Daly, J.; Gillick, C.; Bradley, T.; Sze, E.; Maldonado, R.; Tiwari, A.; Stember, J.; Mankuzhy, N.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save